The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA100206
Max Phase: Preclinical
Molecular Formula: C13H10O4S
Molecular Weight: 262.29
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: O=C(O)CCSC1=CC(=O)c2ccccc2C1=O
Standard InChI: InChI=1S/C13H10O4S/c14-10-7-11(18-6-5-12(15)16)13(17)9-4-2-1-3-8(9)10/h1-4,7H,5-6H2,(H,15,16)
Standard InChI Key: FSELXDDMIGSPLC-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 262.29Molecular Weight (Monoisotopic): 262.0300AlogP: 2.16#Rotatable Bonds: 4Polar Surface Area: 71.44Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0CX Acidic pKa: 3.59CX Basic pKa: CX LogP: 1.49CX LogD: -1.86Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.90Np Likeness Score: 0.16
References 1. Tandon VK, Singh RV, Yadav DB.. (2004) Synthesis and evaluation of novel 1,4-naphthoquinone derivatives as antiviral, antifungal and anticancer agents., 14 (11): [PMID:15125956 ] [10.1016/j.bmcl.2004.03.047 ] 2. Schepetkin IA, Karpenko AS, Khlebnikov AI, Shibinska MO, Levandovskiy IA, Kirpotina LN, Danilenko NV, Quinn MT.. (2019) Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25., 183 [PMID:31563013 ] [10.1016/j.ejmech.2019.111719 ] 3. (2013) Chemical agents for the prevention of inhibition or tumor metastasis, 4. Kwong AJ,Scheidt KA. (2020) Non-'classical' MEKs: A review of MEK3-7 inhibitors., 30 (13): [PMID:32389527 ] [10.1016/j.bmcl.2020.127203 ] 5. Tao Y, Hao X, Ding X, Cherukupalli S, Song Y, Liu X, Zhan P.. (2020) Medicinal chemistry insights into novel CDC25 inhibitors., 201 [PMID:32603979 ] [10.1016/j.ejmech.2020.112374 ]